Xenetic Biosciences, Inc.

XBIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$510-$689-$903-$1,055
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$16$0$25
Change in WC-$164$289-$118$355
Other Non-Cash$16$0$19$0
Operating Cash Flow-$658-$384-$1,002-$674
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$658-$384-$1,002-$674
Supplemental Information
Beg. Cash$4,780$5,164$6,166$6,840
End Cash$4,122$4,780$5,164$6,166
Free Cash Flow-$658-$384-$1,002-$674
Xenetic Biosciences, Inc. (XBIO) Financial Statements & Key Stats | AlphaPilot